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Fragile X Syndrome (FXS) is the most common inheritance cause of intelectual dissability 
(ID) and autism. The prevalence of full mutation was estimated to be 1 in 2633 and the 
premutation 1 in 251. Screening in Indonesia showed that FXS prevalence is 1.9%. The 
advances  of targeted treatments in FXS have led to a newborn and high risk populations of FXS. 
Tassone (2008) introduced a rapid and inexpensive method for screening FMR1 allele sizes 
throughout the pre-mutation and full-mutation range using a dried blood spot  which suitable for 
screening large populations.  
We involved 107 students (67 males and 50 females), ranging from 5-23 years of age  
from special school for ID in Semarang, Central Java, Indonesia. Our preliminary data indicates 
the presence of one male with an expanded allele in this study. Confirmation for the presence of 
a full mutation allele and the determination of the methylation status in this subjects by using 
Southern Blot analysis (standard method), is still in progress.  
As conclusion, blood spots PCR screening is an effective method to conduct a test  in high 
risk population especially in the remote area far from laboratory facilities. We are increasing the 
number of sample to determine the prevalence of FXS in this population and going to implement 
the treatment for individual with FXS.  
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